Here's Why I Still Wouldn't Touch Teladoc With a 10‑Foot Pole

Teladoc Health saw a serious boom during the COVID-19 pandemic, but with stagnant and declining revenue and a lack of profitability, this company looks like it might end up as a relic of a brief but bygone era.Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. And Teladoc Health's (TDOC 3.81%) share price is proof of that.There were a handful of companies back in 2020 that ...